Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Factor Xa Inhibitor”

72 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 72 results

Not applicableStudy completedNCT02464488
What this trial is testing

New Oral Direct Anticoagulants in Patients 80 Years Old and Over : a Population Pharmacokinetics Study

Who this might be right for
Atrial Fibrillation
Hôpital Charles Foix 232
Early research (Phase 1)Study completedNCT03218241
What this trial is testing

Single Ascending Dose Study of PRT064445, a Factor Xa (fXa) Inhibitor Antidote

Who this might be right for
Healthy
Portola Pharmaceuticals 32
Not applicableUnknownNCT04539301
What this trial is testing

Multicentric Prospective Validation of a Universal Test to Quantify Apixaban, Rivaroxaban, Danaparoid and Fondaparinux Levels

Who this might be right for
AnticoagulationVenous ThromboembolismAtrial Fibrillation
Nantes University Hospital 2,100
Testing effectiveness (Phase 2)Study completedNCT00375609
What this trial is testing

Factor Xa Inhibitor, PRT054021, Against Enoxaparin for the Prevention of Venous Thromboembolic Events (EXPERT)

Who this might be right for
Thromboembolism
Portola Pharmaceuticals 215
Testing effectiveness (Phase 2)Study completedNCT00641732
What this trial is testing

Efficacy and Safety of TAK-442 in Subjects Undergoing Total Knee Replacement

Who this might be right for
Venous Thromboembolism
Takeda 1,045
Testing effectiveness (Phase 2)Study completedNCT01203098
What this trial is testing

A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty

Who this might be right for
Venous ThromboembolismThromboembolismThrombosis+3 more
Daiichi Sankyo Co., Ltd. 264
Large-scale testing (Phase 3)Study completedNCT01181141
What this trial is testing

Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Hip Fracture Surgery

Who this might be right for
Venous Thromboembolism
Daiichi Sankyo Co., Ltd. 92
Early research (Phase 1)Study completedNCT05181241
What this trial is testing

Pharmacokinetics, Safety and Tolerability of Dimolegin (DD217)

Who this might be right for
Healthy Volunteers
PharmaDiall Ltd. 24
Large-scale testing (Phase 3)Study completedNCT01181102
What this trial is testing

DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty

Who this might be right for
Venous Thromboembolism
Daiichi Sankyo Co., Ltd. 716
Testing effectiveness (Phase 2)Study completedNCT00786422
What this trial is testing

Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer

Who this might be right for
Venous ThrombosisDeep Vein Thrombosis
Bayer 25
Testing effectiveness (Phase 2)Study completedNCT04640181
What this trial is testing

Factor Xa Inhibitor Versus Standard of Care Heparin in Hospitalized Patients With COVID-19 (XACT)

Who this might be right for
Covid19
St. David's HealthCare 150
Post-approval studies (Phase 4)Looking for participantsNCT06402851
What this trial is testing

Vitamin K AntagonISt, Factor Xa Inhibitor or No Anticoagulation in Atrial Fibrillation and DIalytic End-stage Renal DiseasE (VISIONAIRE)

Who this might be right for
Atrium; FibrillationChronic Kidney Diseases
Hospital Sirio-Libanes 1,500
Large-scale testing (Phase 3)Study completedNCT04142125
What this trial is testing

Combination Antithrombotic Treatment for Prevention of Recurrent Ischemic Stroke in Intracranial Atherosclerotic Disease

Who this might be right for
Ischemic StrokeIntracranial Atherosclerotic Disease
Population Health Research Institute 101
Testing effectiveness (Phase 2)Study completedNCT03088358
What this trial is testing

Safety and Efficacy of TeaRx Xa Factor Direct Inhibitor Versus Enoxaparin as a Venous Thromboembolic Events (VTE) Prevention Following Total Knee Replacement

Who this might be right for
Total Knee Replacement
TeaRx LLC 200
Not applicableStudy completedNCT04611386
What this trial is testing

The Effect of Contrast Agents on the Anticoagulant Properties of Oral Factor Xa Inhibitors

Who this might be right for
Contrast Agents and Oral Factor Xa Inhibitor
Bursa Postgraduate Hospital 65
Large-scale testing (Phase 3)Study completedNCT03996772
What this trial is testing

PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrillation

Who this might be right for
Atrial FibrillationIntracerebral Hemorrhage
Imperial College London 319
Testing effectiveness (Phase 2)Study completedNCT00938730
What this trial is testing

A Study Evaluating Safety and Tolerability of YM150 Compared to Warfarin in Subjects With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Astellas Pharma Inc 1,280
Large-scale testing (Phase 3)Study completedNCT01028950
What this trial is testing

YM150 for Prevention of Venous Thromboembolism in Patients With Acute Medical Illness

Who this might be right for
Venous Thromboembolism
Astellas Pharma Inc 52
Testing effectiveness (Phase 2)Study completedNCT01442792
What this trial is testing

Exploring the Efficacy and Safety of Rivaroxaban to Support Elective Percutaneous Coronary Intervention

Who this might be right for
Cardiovascular DiseaseCoronary Artery Disease
Bayer 108
Testing effectiveness (Phase 2)Ended earlyNCT04233073
What this trial is testing

Trial of Andexanet in Patients Receiving an Oral FXa Inhibitor Who Require Urgent Surgery

Who this might be right for
Surgery
Alexion Pharmaceuticals, Inc. 10
Load More Results